GN
GevRx Nutraceuticals, Inc.
SEC filingBiotechnology · Staten Island, NY
Amount raised$300Ksold at filing
Total offering$3M$2.7M still open
Investors in the raise1count reported to the SEC
FiledSep 18, 2026first sale Sep 11, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dylan Tyler SpielExecutive Officer
James Thomas ChristopherExecutive Officer, Director
Douglas Thomas Spiel, M.D.Executive Officer, Director
Michael J. Betley, Ph.D.Executive Officer
Mary Stephen EspositoDirector
Executive officers, directors and promoters as listed on the Form D.